サインイン

Danlin Yang

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

BIOGRAPHY

Danlin Yang has not added Biography.

If you are Danlin Yang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.

The Journal of biological chemistry Jul, 2016 | Pubmed ID: 27288409

Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics.

Analytical biochemistry Sep, 2016 | Pubmed ID: 27365220

Dataset of the binding kinetic rate constants of anti-PCSK9 antibodies obtained using the Biacore T100, ProteOn XPR36, Octet RED384, and IBIS MX96 biosensor platforms.

Data in brief Sep, 2016 | Pubmed ID: 27547794

INSTITUTIONS

Boehringer Ingelheim Pharmaceuticals, Inc.

JOVE ARTICLES

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Danlin Yang¹,

Ajit Singh²,

Helen Wu¹,

Rachel Kroe-Barrett¹

¹Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.,

²The Fu Foundation School of Engineering and Applied Science, Columbia University

Biochemistry

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Danlin Yang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biotherapeutics Discovery,Immune Modulation and Biotherapeutics Discovery,Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery